In addition, we established a nomogram containing the prognostic factors, such as gender, MGMT status, IDH status, age, ARPC5 expression, 1p19q status, PRS, and grade, to forecast the possibility of 1-, 3-, and 5-year OS in glioma patients. This evidence concerns the gene MGMT and central nervous system cancer.